Skip to content

Evaluating non drug therapies in older people with orthostatic hypotension

Non­drug therapies for orthostatic hypotension in older people: Determining basic efficacy and acceptability

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15084870
Enrollment
25
Registered
2016-12-20
Start date
2015-12-09
Completion date
Unknown
Last updated
2024-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthostatic hypotension (OH) Circulatory System Orthostatic hypotension (OH)

Interventions

Current interventions as of 17/09/2018: Stage 1 After provision of informed consent, participants have their height and weight recorded before being invited to lie down

Sponsors

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 60 years or above 2. Clinical diagnosis of orthostatic hypotension (confirmed with a postural drop in systolic/diastolic blood pressure of at least 20/10 mmHg within 3 minutes of standing upright from a supine position). 3. Able to stand upright

Exclusion criteria

Exclusion criteria: 1. Age below 60 years 2. Dysphagia or previous episode of aspiration 3. Peripheral vascular disease or lower limb ulceration 4. Any contra-indication to bolus water drinking (such as a fluid restriction, cardiac/renal/liver failure) 5. Unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
Postural systolic blood pressure drop is measured using non-invasive, beat-to-beat monitoring (Taskforce Monitor, CNSystems) at baseline (before intervention) and then during each intervention (visit 1 and visit 2).

Secondary

MeasureTime frame
1. Postural diastolic blood pressure drop is measured using non-invasive, beat-to-beat monitoring (Taskforce Monitor, CNSystems) at baseline (before intervention) and then during each intervention (visit 1 and visit 2) 2. Symptoms are measured using the Orthostatic Hypotension Questionnaire Symptom score at baseline and then immediately after orthostatic challenge with each intervention (visit 1 and 2) 3. Acceptability of and barriers to therapy are measured using data from qualitative interviews at visit 3

Countries

England, United Kingdom

Contacts

Public ContactRuth Pearce
ruth.pearce@ncl.ac.uk+44 (0)191 208 3868

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 18, 2026